Global Opioid Use Disorder Market Growth (Status and Outlook) 2025-2031

September 2025 | 82 pages | ID: GE8D7DE1387EN
LP Information

Abstracts

According to this study, the global Opioid Use Disorder market size will reach US$ 2911 million by 2031.

An opioid is a synthetic or natural agent that stimulates opioid receptors and produces opium-like effects. Opioid use disorder is a problematic pattern of opioid use that causes significant impairment or distress.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Opioid Use Disorder Industry Forecast” looks at past sales and reviews total world Opioid Use Disorder sales in 2024, providing a comprehensive analysis by region and market sector of projected Opioid Use Disorder sales for 2025 through 2031. With Opioid Use Disorder sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Opioid Use Disorder industry.

This Insight Report provides a comprehensive analysis of the global Opioid Use Disorder landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Opioid Use Disorder portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Opioid Use Disorder market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Opioid Use Disorder and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Opioid Use Disorder.

This report presents a comprehensive overview, market shares, and growth opportunities of Opioid Use Disorder market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Buprenorphine
• Methadone
• Naltrexone

Segmentation by Application:

• Moderate Pain Treatment
• Severe Pain Treatment

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Indivior
• Alkermes
• Titan Pharmaceuticals
• Hikma Pharmaceuticals
• Teva Pharmaceuticals
• MediciNova
• Orexo
• Camurus
• Omeros

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Opioid Use Disorder Market Size (2020-2031)
  2.1.2 Opioid Use Disorder Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Opioid Use Disorder by Country/Region (2020, 2024 & 2031)
2.2 Opioid Use Disorder Segment by Type
  2.2.1 Buprenorphine
  2.2.2 Methadone
  2.2.3 Naltrexone
2.3 Opioid Use Disorder Market Size by Type
  2.3.1 Opioid Use Disorder Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Opioid Use Disorder Market Size Market Share by Type (2020-2025)
2.4 Opioid Use Disorder Segment by Application
  2.4.1 Moderate Pain Treatment
  2.4.2 Severe Pain Treatment
2.5 Opioid Use Disorder Market Size by Application
  2.5.1 Opioid Use Disorder Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Opioid Use Disorder Market Size Market Share by Application (2020-2025)

3 OPIOID USE DISORDER MARKET SIZE BY PLAYER

3.1 Opioid Use Disorder Market Size Market Share by Player
  3.1.1 Global Opioid Use Disorder Revenue by Player (2020-2025)
  3.1.2 Global Opioid Use Disorder Revenue Market Share by Player (2020-2025)
3.2 Global Opioid Use Disorder Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 OPIOID USE DISORDER BY REGION

4.1 Opioid Use Disorder Market Size by Region (2020-2025)
4.2 Global Opioid Use Disorder Annual Revenue by Country/Region (2020-2025)
4.3 Americas Opioid Use Disorder Market Size Growth (2020-2025)
4.4 APAC Opioid Use Disorder Market Size Growth (2020-2025)
4.5 Europe Opioid Use Disorder Market Size Growth (2020-2025)
4.6 Middle East & Africa Opioid Use Disorder Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Opioid Use Disorder Market Size by Country (2020-2025)
5.2 Americas Opioid Use Disorder Market Size by Type (2020-2025)
5.3 Americas Opioid Use Disorder Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Opioid Use Disorder Market Size by Region (2020-2025)
6.2 APAC Opioid Use Disorder Market Size by Type (2020-2025)
6.3 APAC Opioid Use Disorder Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Opioid Use Disorder Market Size by Country (2020-2025)
7.2 Europe Opioid Use Disorder Market Size by Type (2020-2025)
7.3 Europe Opioid Use Disorder Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Opioid Use Disorder by Region (2020-2025)
8.2 Middle East & Africa Opioid Use Disorder Market Size by Type (2020-2025)
8.3 Middle East & Africa Opioid Use Disorder Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL OPIOID USE DISORDER MARKET FORECAST

10.1 Global Opioid Use Disorder Forecast by Region (2026-2031)
  10.1.1 Global Opioid Use Disorder Forecast by Region (2026-2031)
  10.1.2 Americas Opioid Use Disorder Forecast
  10.1.3 APAC Opioid Use Disorder Forecast
  10.1.4 Europe Opioid Use Disorder Forecast
  10.1.5 Middle East & Africa Opioid Use Disorder Forecast
10.2 Americas Opioid Use Disorder Forecast by Country (2026-2031)
  10.2.1 United States Market Opioid Use Disorder Forecast
  10.2.2 Canada Market Opioid Use Disorder Forecast
  10.2.3 Mexico Market Opioid Use Disorder Forecast
  10.2.4 Brazil Market Opioid Use Disorder Forecast
10.3 APAC Opioid Use Disorder Forecast by Region (2026-2031)
  10.3.1 China Opioid Use Disorder Market Forecast
  10.3.2 Japan Market Opioid Use Disorder Forecast
  10.3.3 Korea Market Opioid Use Disorder Forecast
  10.3.4 Southeast Asia Market Opioid Use Disorder Forecast
  10.3.5 India Market Opioid Use Disorder Forecast
  10.3.6 Australia Market Opioid Use Disorder Forecast
10.4 Europe Opioid Use Disorder Forecast by Country (2026-2031)
  10.4.1 Germany Market Opioid Use Disorder Forecast
  10.4.2 France Market Opioid Use Disorder Forecast
  10.4.3 UK Market Opioid Use Disorder Forecast
  10.4.4 Italy Market Opioid Use Disorder Forecast
  10.4.5 Russia Market Opioid Use Disorder Forecast
10.5 Middle East & Africa Opioid Use Disorder Forecast by Region (2026-2031)
  10.5.1 Egypt Market Opioid Use Disorder Forecast
  10.5.2 South Africa Market Opioid Use Disorder Forecast
  10.5.3 Israel Market Opioid Use Disorder Forecast
  10.5.4 Turkey Market Opioid Use Disorder Forecast
10.6 Global Opioid Use Disorder Forecast by Type (2026-2031)
10.7 Global Opioid Use Disorder Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Opioid Use Disorder Forecast

11 KEY PLAYERS ANALYSIS

11.1 Indivior
  11.1.1 Indivior Company Information
  11.1.2 Indivior Opioid Use Disorder Product Offered
  11.1.3 Indivior Opioid Use Disorder Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Indivior Main Business Overview
  11.1.5 Indivior Latest Developments
11.2 Alkermes
  11.2.1 Alkermes Company Information
  11.2.2 Alkermes Opioid Use Disorder Product Offered
  11.2.3 Alkermes Opioid Use Disorder Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Alkermes Main Business Overview
  11.2.5 Alkermes Latest Developments
11.3 Titan Pharmaceuticals
  11.3.1 Titan Pharmaceuticals Company Information
  11.3.2 Titan Pharmaceuticals Opioid Use Disorder Product Offered
  11.3.3 Titan Pharmaceuticals Opioid Use Disorder Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Titan Pharmaceuticals Main Business Overview
  11.3.5 Titan Pharmaceuticals Latest Developments
11.4 Hikma Pharmaceuticals
  11.4.1 Hikma Pharmaceuticals Company Information
  11.4.2 Hikma Pharmaceuticals Opioid Use Disorder Product Offered
  11.4.3 Hikma Pharmaceuticals Opioid Use Disorder Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Hikma Pharmaceuticals Main Business Overview
  11.4.5 Hikma Pharmaceuticals Latest Developments
11.5 Teva Pharmaceuticals
  11.5.1 Teva Pharmaceuticals Company Information
  11.5.2 Teva Pharmaceuticals Opioid Use Disorder Product Offered
  11.5.3 Teva Pharmaceuticals Opioid Use Disorder Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Teva Pharmaceuticals Main Business Overview
  11.5.5 Teva Pharmaceuticals Latest Developments
11.6 MediciNova
  11.6.1 MediciNova Company Information
  11.6.2 MediciNova Opioid Use Disorder Product Offered
  11.6.3 MediciNova Opioid Use Disorder Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 MediciNova Main Business Overview
  11.6.5 MediciNova Latest Developments
11.7 Orexo
  11.7.1 Orexo Company Information
  11.7.2 Orexo Opioid Use Disorder Product Offered
  11.7.3 Orexo Opioid Use Disorder Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Orexo Main Business Overview
  11.7.5 Orexo Latest Developments
11.8 Camurus
  11.8.1 Camurus Company Information
  11.8.2 Camurus Opioid Use Disorder Product Offered
  11.8.3 Camurus Opioid Use Disorder Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Camurus Main Business Overview
  11.8.5 Camurus Latest Developments
11.9 Omeros
  11.9.1 Omeros Company Information
  11.9.2 Omeros Opioid Use Disorder Product Offered
  11.9.3 Omeros Opioid Use Disorder Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Omeros Main Business Overview
  11.9.5 Omeros Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Opioid Use Disorder Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Opioid Use Disorder Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Buprenorphine
Table 4. Major Players of Methadone
Table 5. Major Players of Naltrexone
Table 6. Opioid Use Disorder Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Opioid Use Disorder Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Opioid Use Disorder Market Size Market Share by Type (2020-2025)
Table 9. Opioid Use Disorder Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Opioid Use Disorder Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Opioid Use Disorder Market Size Market Share by Application (2020-2025)
Table 12. Global Opioid Use Disorder Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Opioid Use Disorder Revenue Market Share by Player (2020-2025)
Table 14. Opioid Use Disorder Key Players Head office and Products Offered
Table 15. Opioid Use Disorder Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Opioid Use Disorder Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Opioid Use Disorder Market Size Market Share by Region (2020-2025)
Table 20. Global Opioid Use Disorder Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Opioid Use Disorder Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Opioid Use Disorder Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Opioid Use Disorder Market Size Market Share by Country (2020-2025)
Table 24. Americas Opioid Use Disorder Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Opioid Use Disorder Market Size Market Share by Type (2020-2025)
Table 26. Americas Opioid Use Disorder Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Opioid Use Disorder Market Size Market Share by Application (2020-2025)
Table 28. APAC Opioid Use Disorder Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Opioid Use Disorder Market Size Market Share by Region (2020-2025)
Table 30. APAC Opioid Use Disorder Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Opioid Use Disorder Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Opioid Use Disorder Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Opioid Use Disorder Market Size Market Share by Country (2020-2025)
Table 34. Europe Opioid Use Disorder Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Opioid Use Disorder Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Opioid Use Disorder Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Opioid Use Disorder Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Opioid Use Disorder Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Opioid Use Disorder
Table 40. Key Market Challenges & Risks of Opioid Use Disorder
Table 41. Key Industry Trends of Opioid Use Disorder
Table 42. Global Opioid Use Disorder Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Opioid Use Disorder Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Opioid Use Disorder Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Opioid Use Disorder Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Indivior Details, Company Type, Opioid Use Disorder Area Served and Its Competitors
Table 47. Indivior Opioid Use Disorder Product Offered
Table 48. Indivior Opioid Use Disorder Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Indivior Main Business
Table 50. Indivior Latest Developments
Table 51. Alkermes Details, Company Type, Opioid Use Disorder Area Served and Its Competitors
Table 52. Alkermes Opioid Use Disorder Product Offered
Table 53. Alkermes Opioid Use Disorder Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Alkermes Main Business
Table 55. Alkermes Latest Developments
Table 56. Titan Pharmaceuticals Details, Company Type, Opioid Use Disorder Area Served and Its Competitors
Table 57. Titan Pharmaceuticals Opioid Use Disorder Product Offered
Table 58. Titan Pharmaceuticals Opioid Use Disorder Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. Titan Pharmaceuticals Main Business
Table 60. Titan Pharmaceuticals Latest Developments
Table 61. Hikma Pharmaceuticals Details, Company Type, Opioid Use Disorder Area Served and Its Competitors
Table 62. Hikma Pharmaceuticals Opioid Use Disorder Product Offered
Table 63. Hikma Pharmaceuticals Opioid Use Disorder Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Hikma Pharmaceuticals Main Business
Table 65. Hikma Pharmaceuticals Latest Developments
Table 66. Teva Pharmaceuticals Details, Company Type, Opioid Use Disorder Area Served and Its Competitors
Table 67. Teva Pharmaceuticals Opioid Use Disorder Product Offered
Table 68. Teva Pharmaceuticals Opioid Use Disorder Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. Teva Pharmaceuticals Main Business
Table 70. Teva Pharmaceuticals Latest Developments
Table 71. MediciNova Details, Company Type, Opioid Use Disorder Area Served and Its Competitors
Table 72. MediciNova Opioid Use Disorder Product Offered
Table 73. MediciNova Opioid Use Disorder Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. MediciNova Main Business
Table 75. MediciNova Latest Developments
Table 76. Orexo Details, Company Type, Opioid Use Disorder Area Served and Its Competitors
Table 77. Orexo Opioid Use Disorder Product Offered
Table 78. Orexo Opioid Use Disorder Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Orexo Main Business
Table 80. Orexo Latest Developments
Table 81. Camurus Details, Company Type, Opioid Use Disorder Area Served and Its Competitors
Table 82. Camurus Opioid Use Disorder Product Offered
Table 83. Camurus Opioid Use Disorder Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. Camurus Main Business
Table 85. Camurus Latest Developments
Table 86. Omeros Details, Company Type, Opioid Use Disorder Area Served and Its Competitors
Table 87. Omeros Opioid Use Disorder Product Offered
Table 88. Omeros Opioid Use Disorder Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Omeros Main Business
Table 90. Omeros Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Opioid Use Disorder Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Opioid Use Disorder Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Opioid Use Disorder Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Opioid Use Disorder Sales Market Share by Country/Region (2024)
Figure 8. Opioid Use Disorder Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Opioid Use Disorder Market Size Market Share by Type in 2024
Figure 10. Opioid Use Disorder in Moderate Pain Treatment
Figure 11. Global Opioid Use Disorder Market: Moderate Pain Treatment (2020-2025) & ($ millions)
Figure 12. Opioid Use Disorder in Severe Pain Treatment
Figure 13. Global Opioid Use Disorder Market: Severe Pain Treatment (2020-2025) & ($ millions)
Figure 14. Global Opioid Use Disorder Market Size Market Share by Application in 2024
Figure 15. Global Opioid Use Disorder Revenue Market Share by Player in 2024
Figure 16. Global Opioid Use Disorder Market Size Market Share by Region (2020-2025)
Figure 17. Americas Opioid Use Disorder Market Size 2020-2025 ($ millions)
Figure 18. APAC Opioid Use Disorder Market Size 2020-2025 ($ millions)
Figure 19. Europe Opioid Use Disorder Market Size 2020-2025 ($ millions)
Figure 20. Middle East & Africa Opioid Use Disorder Market Size 2020-2025 ($ millions)
Figure 21. Americas Opioid Use Disorder Value Market Share by Country in 2024
Figure 22. United States Opioid Use Disorder Market Size Growth 2020-2025 ($ millions)
Figure 23. Canada Opioid Use Disorder Market Size Growth 2020-2025 ($ millions)
Figure 24. Mexico Opioid Use Disorder Market Size Growth 2020-2025 ($ millions)
Figure 25. Brazil Opioid Use Disorder Market Size Growth 2020-2025 ($ millions)
Figure 26. APAC Opioid Use Disorder Market Size Market Share by Region in 2024
Figure 27. APAC Opioid Use Disorder Market Size Market Share by Type (2020-2025)
Figure 28. APAC Opioid Use Disorder Market Size Market Share by Application (2020-2025)
Figure 29. China Opioid Use Disorder Market Size Growth 2020-2025 ($ millions)
Figure 30. Japan Opioid Use Disorder Market Size Growth 2020-2025 ($ millions)
Figure 31. South Korea Opioid Use Disorder Market Size Growth 2020-2025 ($ millions)
Figure 32. Southeast Asia Opioid Use Disorder Market Size Growth 2020-2025 ($ millions)
Figure 33. India Opioid Use Disorder Market Size Growth 2020-2025 ($ millions)
Figure 34. Australia Opioid Use Disorder Market Size Growth 2020-2025 ($ millions)
Figure 35. Europe Opioid Use Disorder Market Size Market Share by Country in 2024
Figure 36. Europe Opioid Use Disorder Market Size Market Share by Type (2020-2025)
Figure 37. Europe Opioid Use Disorder Market Size Market Share by Application (2020-2025)
Figure 38. Germany Opioid Use Disorder Market Size Growth 2020-2025 ($ millions)
Figure 39. France Opioid Use Disorder Market Size Growth 2020-2025 ($ millions)
Figure 40. UK Opioid Use Disorder Market Size Growth 2020-2025 ($ millions)
Figure 41. Italy Opioid Use Disorder Market Size Growth 2020-2025 ($ millions)
Figure 42. Russia Opioid Use Disorder Market Size Growth 2020-2025 ($ millions)
Figure 43. Middle East & Africa Opioid Use Disorder Market Size Market Share by Region (2020-2025)
Figure 44. Middle East & Africa Opioid Use Disorder Market Size Market Share by Type (2020-2025)
Figure 45. Middle East & Africa Opioid Use Disorder Market Size Market Share by Application (2020-2025)
Figure 46. Egypt Opioid Use Disorder Market Size Growth 2020-2025 ($ millions)
Figure 47. South Africa Opioid Use Disorder Market Size Growth 2020-2025 ($ millions)
Figure 48. Israel Opioid Use Disorder Market Size Growth 2020-2025 ($ millions)
Figure 49. Turkey Opioid Use Disorder Market Size Growth 2020-2025 ($ millions)
Figure 50. GCC Countries Opioid Use Disorder Market Size Growth 2020-2025 ($ millions)
Figure 51. Americas Opioid Use Disorder Market Size 2026-2031 ($ millions)
Figure 52. APAC Opioid Use Disorder Market Size 2026-2031 ($ millions)
Figure 53. Europe Opioid Use Disorder Market Size 2026-2031 ($ millions)
Figure 54. Middle East & Africa Opioid Use Disorder Market Size 2026-2031 ($ millions)
Figure 55. United States Opioid Use Disorder Market Size 2026-2031 ($ millions)
Figure 56. Canada Opioid Use Disorder Market Size 2026-2031 ($ millions)
Figure 57. Mexico Opioid Use Disorder Market Size 2026-2031 ($ millions)
Figure 58. Brazil Opioid Use Disorder Market Size 2026-2031 ($ millions)
Figure 59. China Opioid Use Disorder Market Size 2026-2031 ($ millions)
Figure 60. Japan Opioid Use Disorder Market Size 2026-2031 ($ millions)
Figure 61. Korea Opioid Use Disorder Market Size 2026-2031 ($ millions)
Figure 62. Southeast Asia Opioid Use Disorder Market Size 2026-2031 ($ millions)
Figure 63. India Opioid Use Disorder Market Size 2026-2031 ($ millions)
Figure 64. Australia Opioid Use Disorder Market Size 2026-2031 ($ millions)
Figure 65. Germany Opioid Use Disorder Market Size 2026-2031 ($ millions)
Figure 66. France Opioid Use Disorder Market Size 2026-2031 ($ millions)
Figure 67. UK Opioid Use Disorder Market Size 2026-2031 ($ millions)
Figure 68. Italy Opioid Use Disorder Market Size 2026-2031 ($ millions)
Figure 69. Russia Opioid Use Disorder Market Size 2026-2031 ($ millions)
Figure 70. Egypt Opioid Use Disorder Market Size 2026-2031 ($ millions)
Figure 71. South Africa Opioid Use Disorder Market Size 2026-2031 ($ millions)
Figure 72. Israel Opioid Use Disorder Market Size 2026-2031 ($ millions)
Figure 73. Turkey Opioid Use Disorder Market Size 2026-2031 ($ millions)
Figure 74. Global Opioid Use Disorder Market Size Market Share Forecast by Type (2026-2031)
Figure 75. Global Opioid Use Disorder Market Size Market Share Forecast by Application (2026-2031)
Figure 76. GCC Countries Opioid Use Disorder Market Size 2026-2031 ($ millions)